Free Trial

Arrowhead Pharmaceuticals (ARWR) Insider Trading & Ownership

$18.82
-0.03 (-0.16%)
(As of 10/4/2024 08:49 PM ET)

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.50%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$54,990.00
Number Of
Insiders Selling
(Last 12 Months)
8
Amount Of
Insider Selling
(Last 12 Months)
$8.75 M
Get ARWR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Arrowhead Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ARWR Insider Buying and Selling by Quarter

Arrowhead Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/2/2024Tracie OliverInsiderSell9,394$25.28$237,480.32  
5/2/2024Victoria VakienerDirectorSell1,799$23.31$41,934.69  
3/20/2024Hongbo LuDirectorBuy1,000$27.50$27,500.00  
3/18/2024Hongbo LuDirectorBuy1,000$27.49$27,490.00  
3/6/2024Kenneth Allen MyszkowskiCFOSell40,000$35.19$1,407,600.00  
1/31/2024Christopher Richard AnzaloneCEOSell57,499$32.35$1,860,092.65  
50-Yr Wall Street Legend: “Sell this AI stock NOW” (Ad)

Nearly 1 million people around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And in the aftermath of the biggest tech selloff since 2022...

He just gave them an urgent SELL alert for one beloved AI stock.
1/12/2024James C HamiltonInsiderSell7,940$36.89$292,906.60  
1/11/2024Douglas B GivenDirectorSell2,911$38.06$110,792.66  
1/5/2024James C HamiltonInsiderSell32,143$35.18$1,130,790.74  
1/5/2024Kenneth Allen MyszkowskiCFOSell16,104$35.27$567,988.08  
1/5/2024Patrick O'brienCOOSell22,841$35.27$805,602.07  
1/3/2024James C HamiltonInsiderSell6,300$32.19$202,797.00  
1/3/2024Patrick O'brienCOOSell8,749$32.28$282,417.72  
1/2/2024Christopher Richard AnzaloneCEOSell9,952$31.01$308,611.52  
12/20/2023Christopher Richard AnzaloneCEOSell12,000$28.54$342,480.00  
11/20/2023Martin Javier SanInsiderSell19,700$28.80$567,360.00  
10/25/2023Christopher Richard AnzaloneCEOSell24,338$24.21$589,222.98  
(Data available from 1/1/2013 forward)

ARWR Insider Trading Activity - Frequently Asked Questions

The list of insiders at Arrowhead Pharmaceuticals includes Adeoye Y Olukotun, Christopher Richard Anzalone, Douglas B Given, Hongbo Lu, James C Hamilton, Kenneth Allen Myszkowski, Martin Javier San, Patrick O'brien, Tracie Oliver, Victoria Vakiener, and William D Waddill. Learn more on insiders at ARWR.

4.50% of Arrowhead Pharmaceuticals stock is owned by insiders. Learn more on ARWR's insider holdings.

The following insider purchased ARWR shares in the last 24 months: Hongbo Lu ($54,990.00).

Insiders have purchased a total of 2,000 ARWR shares in the last 24 months for a total of $54,990.00 bought.

The following insiders have sold ARWR shares in the last 24 months: Adeoye Y Olukotun ($370,577.50), Christopher Richard Anzalone ($6,874,359.67), Douglas B Given ($405,185.16), James C Hamilton ($2,646,088.98), Kenneth Allen Myszkowski ($3,743,588.08), Martin Javier San ($1,152,165.00), Patrick O'brien ($2,319,644.79), Tracie Oliver ($552,622.07), Victoria Vakiener ($82,746.19), and William D Waddill ($96,000.00).

Insiders have sold a total of 541,519 Arrowhead Pharmaceuticals shares in the last 24 months for a total of $18,242,977.44 sold.

Arrowhead Pharmaceuticals Key Executives



This page (NASDAQ:ARWR) was last updated on 10/7/2024 by MarketBeat.com Staff
From Our Partners